Technical Data
S9500-03H
Synuclein, alpha (SNCA, Alpha Synuclein, MGC110988, Non-A beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, PARK1, PARK4, Parkinson Disease Familial 1, PD1)
Description:
Alpha synuclein is an abundant 140 amino acid neuronal protein, expressed primarily at presynaptic terminals in the central nervous system. Alpha synuclein has been associated with several neurodegenerative diseases. A point mutation in the gene coding for the alpha-synuclein protein was the first discovery linking this protein to a rare familial form of Parkinson's disease (PD). Subsequently, other mutations in the alpha-synuclein gene have been identified in familial PD. The aggregated proteinaceous inclusions called Lewy bodies found in PD and cortical Lewy body dementia (LBD) were discovered to be predominantly alpha-synuclein. Aberrant aggregation of alpha-synuclein has been detected in an increasing number of neurodegenerative diseases, collectively known as synucleopathies. Alpha-synuclein exists physiologically in both soluble and membrane-bound states, in unstructured and alpha-helical conformations, respectively. The physiological function of alpha-synuclein appears to require its translocation between these subcellular compartments and interconversion between the 2 conformations. Abnormal processing of alpha-synuclein is predicted to lead to pathological changes in its binding properties and function.

Applications:
Suitable for use in Immunohistochemistry. Other applications have not been tested.

Recommended Dilution:
Immunohistochemistry: 1:1000-1:2000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
PabIgGSerum
SizeStorageShippingSourceHost
100ul-20CBlue IceHumanSheep
Concentration:
Not determined.
Immunogen:
A synthetic peptide correspondingto aa116-131, CMPVDPDNEAYEMPSEE of human alpha synuclein (KLH).
Purity:
Serum
Form
Supplied as a lyophilized powder. Reconstitute in 100ul of sterile ddH2O. Centrifuge to remove any insoluble material.
Specificity:
Recognizes human alpha-synuclein. Species Crossreactivity: Rat, mouse.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Lundvig, et al Brain Res Mol Brain Res 134, 3-17 (Mar 24, 2005). 2. Bennett, Pharmacol Ther 105, 311-31 (Mar, 2005). 3. Vekrellis, et al., Mol Neurobiol 30, 1-21 (Aug, 2004). 4. Martin, et al., Protein Pept Lett 11, 229-37 (Jun, 2004). 5. Doherty, et al., Acta Neuropathol (Berl) 107, 169-75 (Feb, 2004). 6. Goedert, Curr Opin Genet Dev 11, 343-51 (Jun, 2001). 7. Saito, et al., J Neurol Sci 177, 48-59 (Aug 1, 2000). 8. Lucking, et al., Cell Mol Life Sci 57, 1894-908 (Dec, 2000). 9. Kahle, et al., Ann N Y Acad Sci 920, 33-41 (2000). 10. Clayton, et al., Trends Neurosci 21, 249-54 (Jun, 1998).